AgingResearch.NewsJoin free

Old CD150LOW hematopoietic stem cell transplantation

Old CD150LOW hematopoietic stem cell transplantation has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 2, 2025: “Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice”.

Intervention

1 paper studies it1 findingUpdated

See all 1

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funder: Howard Hughes Medical Institute
  • Animals1

What did studies of Old CD150LOW hematopoietic stem cell transplantation find?

1

Studies of Old CD150LOW hematopoietic stem cell transplantation measured 1 outcome; the most studied are lifespan (1 study).

Lifespan

upin mice1

1 study

  1. Old CD150LOW hematopoietic stem cell transplantation extends lifespan in mice (compared to unselected or CD150high HSCs).

    “transplantation of old CD150low HSCs attenuates aging phenotypes and prolongs lifespan of elderly mice”

    Animalscompared to unselected or CD150high HSCs

    Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice

    Cell research

Latest

Related